Rehab Success Rates: What the Data Actually Shows

Key Takeaways

• NIDA estimates that 40-60% of people treated for substance use disorders experience relapse, a rate comparable to relapse rates for hypertension (50-70%) and asthma (50-70%) (NIDA, 2024).
• Treatment completion rates vary widely by modality: approximately 50-65% for residential programs and 30-45% for outpatient programs, according to SAMHSA TEDS (2023).
• Patients who remain in treatment for at least 90 days have significantly better long-term outcomes than those in shorter programs (NIDA Principles of Drug Addiction Treatment, 2018).
• Medication-assisted treatment for opioid use disorder reduces all-cause mortality by approximately 50%, according to a 2020 meta-analysis published in The BMJ (Santo et al., 2021).
• Facilities that claim success rates above 90% are typically using non-standardized definitions or selective follow-up (NIDA, 2024).

Statistics updated quarterly. Last reviewed March 28, 2026.

---

The question of rehab success rates is among the most searched topics in the addiction treatment space, and also among the most misunderstood. The straightforward answer that many people seek does not exist in a meaningful form, because “success” in addiction treatment has no universal definition. This page examines what rigorous research actually shows about treatment outcomes, why published success rates from individual facilities should be viewed skeptically, and how to think about treatment effectiveness in evidence-based terms.

The Problem with Rehab Success Rates

How Success Is Defined (and Why It Varies)

There is no standardized definition of “success” in addiction treatment. Different studies and different facilities use different measures, which makes direct comparisons unreliable. Common definitions include:

• Program completion: Did the patient finish the prescribed treatment program? This is the easiest to measure but says little about long-term outcomes.
• Abstinence at discharge: Was the patient substance-free when they left? This favors residential programs where patients have no access to substances.
• Abstinence at 30 days post-discharge: This captures early post-treatment sobriety but misses the most critical relapse period.
• Abstinence at one year: A more meaningful measure, but harder to track because many patients are lost to follow-up.
• Reduction in substance use: Some researchers argue that any sustained reduction in use represents a meaningful clinical improvement, even if total abstinence is not achieved.
• Functional improvement: Employment, housing stability, reduced emergency department visits, and improved family relationships are all outcomes that matter clinically.

The National Institute on Drug Abuse (NIDA) has recommended that the addiction field move toward standardized outcome measures, but as of 2024, no single metric has been universally adopted (NIDA, 2024). This means that when a treatment facility publishes a “success rate,” the number is only as meaningful as its definition, follow-up period, and measurement methodology, none of which are typically disclosed.

Why Published Rates Are Often Misleading

Many treatment facilities advertise success rates that range from 60% to 90% or higher. These numbers should be interpreted with significant caution for several reasons:

• Selective follow-up: Facilities may only track patients who respond to follow-up surveys, introducing survivorship bias. Patients who relapse or disengage are less likely to respond (Miller et al., Addiction, 2020).
• Short follow-up windows: A success rate measured at 30 days post-discharge will be higher than one measured at one year.
• Non-standardized definitions: One facility’s “success” may be program completion, while another’s may be abstinence at six months.
• Unmeasured confounders: Facilities that serve voluntary, privately insured patients with strong family support will naturally report higher success rates than those serving court-mandated or uninsured populations, regardless of treatment quality.

The Federal Trade Commission (FTC) has issued warnings to treatment facilities about misleading success rate claims, noting that unsubstantiated outcome claims in addiction treatment marketing are deceptive under FTC guidelines (FTC, 2020).

What Rigorous Research Shows

NIDA-Funded Study Outcomes

Large-scale, federally funded studies provide the most reliable data on treatment outcomes. Key findings include:

Relapse rates are comparable to other chronic diseases. NIDA reports that 40-60% of people treated for substance use disorders will experience relapse at some point. This rate is similar to relapse rates for other chronic conditions: hypertension (50-70%), type 1 diabetes (30-50%), and asthma (50-70%) (NIDA, 2024). This comparison is not meant to minimize relapse but to contextualize it within the framework of chronic disease management.

Treatment substantially improves outcomes compared to no treatment. A longitudinal study funded by SAMHSA, the Drug Abuse Treatment Outcome Studies (DATOS), followed over 10,000 patients across 96 treatment programs. The study found that drug use decreased by 50-70% in the year following treatment, and criminal behavior decreased by 60% (Simpson et al., Archives of General Psychiatry, 1999; Hubbard et al., Drug and Alcohol Dependence, 2003).

Treatment reduces mortality. A 2020 meta-analysis published in The Lancet Psychiatry found that engagement in any form of substance use treatment significantly reduced all-cause mortality among people with opioid use disorder. Medication-assisted treatment (specifically methadone and buprenorphine) reduced mortality by approximately 50% (Santo et al., The BMJ, 2021).

Long-Term Follow-Up Data

The most informative outcome data comes from studies with long follow-up periods:

• The DATOS study found that at five years post-treatment, approximately 25-35% of patients who completed residential treatment reported sustained abstinence, while an additional 30-40% reported significant reduction in use (Hubbard et al., 2003).
• A 2022 study published in Drug and Alcohol Dependence tracked 1,500 patients for three years after treatment discharge and found that 34% achieved sustained remission (defined as no SUD diagnosis at three-year follow-up), while an additional 28% achieved partial remission with significant improvement in functioning (Dennis et al., Drug and Alcohol Dependence, 2022).
• The Recovery Research Institute at Massachusetts General Hospital has documented that after five years of sustained recovery, the probability of maintaining recovery exceeds 85% (Kelly et al., Alcoholism: Clinical and Experimental Research, 2019).

Factors That Improve Rehab Success Rates

Treatment Duration

Treatment duration is one of the strongest and most consistent predictors of positive outcomes. NIDA’s Principles of Drug Addiction Treatment (2018) states that research consistently demonstrates that treatment lasting less than 90 days has limited effectiveness, and that outcomes improve significantly with longer durations.

According to data from the National Treatment Improvement Evaluation Study (NTIES), patients who remained in residential treatment for at least 90 days were approximately 1.5 times more likely to remain abstinent at one-year follow-up compared to those who stayed for 30 days or fewer (SAMHSA/CSAT, 2000).

Use of Medication-Assisted Treatment

For opioid use disorder specifically, the evidence supporting medication-assisted treatment (MAT) is strong. According to NIDA (2024):

• Buprenorphine reduces opioid use by approximately 45-60% compared to placebo in randomized controlled trials.
• Methadone maintenance reduces illicit opioid use by approximately 60-70% and reduces overdose mortality by approximately 50%.
• Naltrexone (extended-release/Vivitrol) reduces relapse risk by approximately 36% compared to placebo among patients who successfully initiate treatment.

A 2023 systematic review published in The Lancet confirmed that MAT remains the gold standard for opioid use disorder, with the strongest evidence base of any addiction treatment intervention (Mattick et al., The Lancet, 2023).

Aftercare Engagement

Post-treatment engagement is critical. Research consistently shows that patients who participate in aftercare programming, including outpatient counseling, mutual aid meetings, recovery coaching, or medication management, have better long-term outcomes than those who do not.

A 2021 study in the Journal of Substance Abuse Treatment found that patients who engaged in at least six months of aftercare following residential treatment were 2.1 times more likely to maintain abstinence at two-year follow-up compared to those who did not engage in aftercare (McKay et al., Journal of Substance Abuse Treatment, 2021).

Why Comparing Rehab Centers by Success Rate Is Flawed

Selection Bias

Treatment facilities serve different patient populations. A private residential program in a suburban setting that screens for motivation and requires insurance pre-authorization will have inherently different outcomes than a state-funded program that accepts court-mandated referrals, patients with no stable housing, and individuals with severe co-occurring psychiatric conditions. Comparing their “success rates” is comparing different populations, not different treatment quality.

This is a well-documented phenomenon in outcomes research called selection bias. A 2020 analysis published in Addiction demonstrated that after controlling for patient characteristics (severity of addiction, psychiatric comorbidity, housing stability, employment, and social support), differences in outcomes between facilities decreased substantially (Garnick et al., Addiction, 2020).

What to Look for Instead

Rather than asking about a facility’s success rate, more informative questions include:

• Accreditation status: Is the facility accredited by CARF or the Joint Commission? These bodies require standardized quality measures.
• Evidence-based practices: Does the facility use treatments supported by research, including MAT where indicated, cognitive-behavioral therapy (CBT), and motivational interviewing?
• Aftercare planning: Does the program include a structured aftercare plan, or does treatment end abruptly at discharge?
• Staff credentials: Are clinical staff licensed and credentialed appropriately?
• Outcome measurement: Does the facility track outcomes using validated instruments, even if results are not publicly marketed?

A Better Way to Think About Treatment Outcomes

The Chronic Disease Management Model

NIDA has consistently recommended that addiction be understood and treated as a chronic, relapsing brain disorder, analogous to conditions like diabetes, hypertension, and asthma (NIDA, 2024). Under this framework:

• A single episode of treatment is not expected to produce permanent results, just as a single course of blood pressure medication does not permanently resolve hypertension.
• Relapse is a signal to adjust treatment, not evidence that treatment has failed.
• Long-term management, including ongoing medication, counseling, and monitoring, produces the best outcomes.

This model is supported by the research. The chronic disease comparison is not just an analogy; the biological and behavioral mechanisms are genuinely parallel. The relapse rates, the role of adherence to treatment, and the importance of long-term management are structurally similar across these conditions (McLellan et al., JAMA, 2000).

Measuring Progress Beyond Abstinence

A growing body of research supports the view that outcomes should be measured on a continuum rather than as a binary (abstinent/relapsed). SAMHSA’s definition of recovery recognizes that recovery is a process of change through which individuals improve their health and wellness, live self-directed lives, and strive to reach their full potential (SAMHSA, 2012).

Clinically meaningful improvements include reduced substance use frequency and quantity, decreased emergency department visits and hospitalizations, improved employment and housing stability, reduced criminal justice involvement, and improved mental health functioning. These outcomes matter for individuals, families, and communities even when total abstinence is not immediately achieved.

---

This page is part of the Addiction Statistics, Research, and Recovery Data guide on NJ Addiction Centers.

Related resources:

• Drug Addiction Recovery Rates and Long-Term Outcomes
• Success Rate of 30-Day Rehab Programs
• Relapse Rates After Treatment
• Questions to Ask Before Choosing a Rehab Facility